Analysis of Nef-induced MHC-I endocytosis

[1] NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J]. CELL, 1994, 76 (05) : 853 - 864

[2] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056

[3] THE CYTOPLASMIC DOMAIN OF CD4 IS SUFFICIENT FOR ITS DOWN-REGULATION FROM THE CELL-SURFACE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 3092 - 3101

[4] IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J]. CELL, 1985, 43 (01) : 215 - 222

[5] CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J]. SCIENCE, 1992, 258 (5090) : 1935 - 1938

[6] BEERSMA MFC, 1993, J IMMUNOL, V151, P4455

[7] BENICHOU S, 1994, J BIOL CHEM, V269, P30073

[8] BEVAN MJ, 1995, P NATL ACAD SCI USA, V92, P5766

[9] THE GROWTH ADVANTAGE CONFERRED BY HIV-1 NEF IS DETERMINED AT THE LEVEL OF VIRAL-DNA FORMATION AND IS INDEPENDENT OF CD4 DOWN-REGULATION [J]. VIROLOGY, 1995, 212 (02) : 451 - 457

[10] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J]. SCIENCE, 1995, 267 (5197) : 483 - 489

[1] NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J]. CELL, 1994, 76 (05) : 853 - 864

[2] NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 5048 - 5056

[3] THE CYTOPLASMIC DOMAIN OF CD4 IS SUFFICIENT FOR ITS DOWN-REGULATION FROM THE CELL-SURFACE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 3092 - 3101

[4] IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J]. CELL, 1985, 43 (01) : 215 - 222

[5] CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J]. SCIENCE, 1992, 258 (5090) : 1935 - 1938

[6] BEERSMA MFC, 1993, J IMMUNOL, V151, P4455

[7] BENICHOU S, 1994, J BIOL CHEM, V269, P30073

[8] BEVAN MJ, 1995, P NATL ACAD SCI USA, V92, P5766

[9] THE GROWTH ADVANTAGE CONFERRED BY HIV-1 NEF IS DETERMINED AT THE LEVEL OF VIRAL-DNA FORMATION AND IS INDEPENDENT OF CD4 DOWN-REGULATION [J]. VIROLOGY, 1995, 212 (02) : 451 - 457

[10] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J]. SCIENCE, 1995, 267 (5197) : 483 - 489